Chemoprevention Therapy in Treating Patients at High Risk of Developing Multiple Myeloma
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. Dehydroepiandrosterone and clarithromycin may be
effective in preventing multiple myeloma.
PURPOSE: Randomized phase II trial to compare the effectiveness of dehydroepiandrosterone
with that of clarithromycin in treating patients who may be at a high risk of developing
multiple myeloma.